These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25888995)

  • 1. How much of the productivity losses among psoriasis patients are due to psoriasis.
    Mustonen A; Mattila K; Leino M; Koulu L; Tuominen R
    BMC Health Serv Res; 2015 Mar; 15():87. PubMed ID: 25888995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study.
    Feldman SR; Zhao Y; Gilloteau I; Graham CN; Miles L; McBride D; Herrera V
    J Manag Care Spec Pharm; 2018 Jul; 24(7):617-622. PubMed ID: 29952701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.
    Bouwmans C; Krol M; Severens H; Koopmanschap M; Brouwer W; Hakkaart-van Roijen L
    Value Health; 2015 Sep; 18(6):753-8. PubMed ID: 26409601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secukinumab significantly reduces psoriasis-related work impairment and indirect costs compared with ustekinumab and etanercept in the United Kingdom.
    Warren RB; Halliday A; Graham CN; Gilloteau I; Miles L; McBride D
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2178-2184. PubMed ID: 29846965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
    Kotseva K; Gerlier L; Sidelnikov E; Kutikova L; Lamotte M; Amarenco P; Annemans L
    Eur J Prev Cardiol; 2019 Jul; 26(11):1150-1157. PubMed ID: 30955367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of psoriasis on work.
    Mattila K; Leino M; Mustonen A; Koulu L; Tuominen R
    Eur J Dermatol; 2013 Apr; 23(2):208-11. PubMed ID: 23558018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis.
    Zhang W; Bansback N; Boonen A; Severens JL; Anis AH
    Value Health; 2012 Jan; 15(1):46-54. PubMed ID: 22264971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.
    Rafia R; Ara R; Packham J; Haywood KL; Healey E
    Clin Exp Rheumatol; 2012; 30(2):246-53. PubMed ID: 22409861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects.
    Krol M; Brouwer WB; Severens JL; Kaper J; Evers SM
    Soc Sci Med; 2012 Dec; 75(11):1981-8. PubMed ID: 22925428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].
    Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J
    Z Rheumatol; 2006 Oct; 65(6):527-34. PubMed ID: 16534538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis.
    Schmitt J; Küster D
    Arch Dermatol Res; 2015 Jul; 307(5):451-3. PubMed ID: 25940274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social costs of loss in productivity-related absenteeism in Poland.
    Genowska A; Fryc J; Pinkas J; Jamiołkowski J; Szafraniec K; Szpak A; Bojar I
    Int J Occup Med Environ Health; 2017 Oct; 30(6):917-932. PubMed ID: 28584315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of lost productivity in inflammatory arthritis and osteoarthritis in the year before and after diagnosis: An inception cohort study.
    Xiang L; Graves N; Low AHL; Leung YY; Fong W; Gan WH; Gandhi M; Thumboo J
    Int J Rheum Dis; 2024 Jul; 27(7):e15252. PubMed ID: 38982887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment-Related Problems on Reductions in Productivity from a Managerial Perspective.
    Strömberg C; Aboagye E; Hagberg J; Bergström G; Lohela-Karlsson M
    Value Health; 2017 Sep; 20(8):1058-1064. PubMed ID: 28964437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of psoriasis on professional life: PsoPRO, a French national survey.
    Claudepierre P; Lahfa M; Levy P; Barnetche T; Bonnet I; Aubert R; Roquelaure Y
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1702-1709. PubMed ID: 29633363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
    Holko P; Kawalec P; Mossakowska M; Pilc A
    PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presenteeism, Absenteeism, and Lost Work Productivity among Depressive Patients from Five Cities of Colombia.
    Uribe JM; Pinto DM; Vecino-Ortiz AI; Gómez-Restrepo C; Rondón M
    Value Health Reg Issues; 2017 Dec; 14():15-19. PubMed ID: 29254536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden of moderate to severe plaque psoriasis in Canada.
    Levy AR; Davie AM; Brazier NC; Jivraj F; Albrecht LE; Gratton D; Lynde CW
    Int J Dermatol; 2012 Dec; 51(12):1432-40. PubMed ID: 23171010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches.
    Pearce AM; Hanly P; Timmons A; Walsh PM; O'Neill C; O'Sullivan E; Gooberman-Hill R; Thomas AA; Gallagher P; Sharp L
    Appl Health Econ Health Policy; 2015 Aug; 13(4):359-67. PubMed ID: 25691128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems in work participation and resource use should not be underestimated in patients with early spondyloarthritis.
    van der Weijden MA; Boonen A; van der Horst-Bruinsma IE
    J Rheumatol; 2014 Dec; 41(12):2413-20. PubMed ID: 25320217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.